The Valley Desk

NCT03964415 · Interventional trial

A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals

Overall registry status Completed

Phase 3

Conditions Healthy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov